| Date Filed | Type | Description |
| 01/09/2023 |
4
| Crowley John J (CFO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 250,000 options to buy
@ $3.75, valued at
$937.5k
|
|
| 02/03/2022 |
4
| Crowley John J (CFO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 3,910 shares
@ $0
Granted 167,000 options to buy
@ $7.7, valued at
$1.3M
|
|
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Crowley John J (CFO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Bought 6,500 shares
@ $17, valued at
$110.5k
|
|
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/03/2013 |
4
| Crowley John J (SVP, Chief Accounting Officer) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL INC|
Txns:
| Granted 3,500 shares
@ $0
Granted 4,000 options to buy
@ $46.62, valued at
$186.5k
|
|
| 10/03/2013 |
3
| Crowley John J (SVP, Chief Accounting Officer) has filed a Form 3 on CHARLES RIVER LABORATORIES INTERNATIONAL INC |